This conference marks the 20th anniversary of breakthrough discoveries in induced pluripotent stem cell (iPSC) technology, which have revolutionized embryology, disease modeling, drug discovery, and cell-based therapies. Looking ahead, the integration of iPSCs with gene editing, organoids, organs-on-a-chip, AI, and machine learning promises to yield even more powerful and transformative applications in biomedical research and clinical medicine. 

This meeting will celebrate past advances and future opportunities, bringing together leaders from academia, industry, and medicine to discuss iPSC applications now advancing into clinical trials. Topics include innovative technologies and applications in disease modeling, drug discovery, cell therapy development, organoid platforms, and more, along with critical discussions on bioethics. A highlight will be the Keynote Address by Nobel Laureate Dr. Shinya Yamanaka, co-organizer of the meeting. By fostering cross-disciplinary collaboration, this conference will accelerate innovation and translation of iPSC research into transformative therapies. 

In the video below, Nobel Prize laureate Dr. Shinya Yamanaka from the Center for iPS Cell Research and Application, talks about why you should attend this meeting:

Also, check out the speaker highlights in the video below: